Foto del docente

Fabiana Morroni

Associate Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/14 Pharmacology

Teaching

Exam sessions

List of exam sessions published until now, divided by course unit. For detailed information, please go to AlmaEsami

62170 - Pharmacovigilance and Pharmacoepidemiology

Degree programme:
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 9219)
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 5985)
When:
April 3, 2024 at 09:00
Subscriptions list:
opened from 19/03/2024 to 01/04/2024
Test type:
Oral exam
Place:
Aula Magna Anatomia - via Irnerio 48, 40126 Bologna
Degree programme:
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 9219)
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 5985)
When:
June 19, 2024 at 09:00
Subscriptions list:
opened from 04/06/2024 to 17/06/2024
Test type:
Oral exam
Place:
aula A Farmacologia - via Irnerio 48, Bologna
Degree programme:
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 9219)
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 5985)
When:
July 3, 2024 at 09:00
Subscriptions list:
opened from 18/06/2024 to 01/07/2024
Test type:
Oral exam
Place:
aula A Farmacologia, via Irnerio 48, Bologna
Degree programme:
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 9219)
Laurea Magistrale a ciclo unico (Single cycle degree/Combined Bachelor and Master - 300/360 ECTS) in Pharmacy (cod. 5985)
When:
September 16, 2024 at 09:00
Subscriptions list:
opened from 01/09/2024 to 14/09/2024
Test type:
Oral exam
Place:
aula A Farmacologia, via Irnerio 48, Bologna

Latest news

At the moment no news are available.